WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) Short Interest Update

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) was the recipient of a large decrease in short interest during the month of January. As of January 30th, there was short interest totaling 4,990 shares, a decrease of 23.3% from the January 15th total of 6,507 shares. Based on an average daily trading volume, of 3,289 shares, the short-interest ratio is presently 1.5 days. Based on an average daily trading volume, of 3,289 shares, the short-interest ratio is presently 1.5 days.

Analysts Set New Price Targets

Separately, The Goldman Sachs Group raised WuXi AppTec to a “buy” rating in a research note on Thursday, February 5th. One analyst has rated the stock with a Buy rating, Based on data from MarketBeat, the company presently has an average rating of “Buy”.

WuXi AppTec Stock Down 4.8%

Shares of OTCMKTS:WUXAY opened at $15.22 on Friday. The stock’s 50-day moving average price is $13.96 and its 200-day moving average price is $13.83. WuXi AppTec has a 12-month low of $5.73 and a 12-month high of $16.35.

WuXi AppTec Company Profile

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.